Cardiol Therapeutics Cash Flow Statement 2021-2024 | CRDL

Fifteen years of historical annual cash flow statements for Cardiol Therapeutics (CRDL).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021
$-20.84$-23.79$-25.24
$0.18$0.17$0.18
$2.40$-1.73$6.22
$2.59$-1.56$6.39
$0.05$-0.11$-0.05
$0$0$0.01
$0$0$0
$0.50$1.09$-1.81
$-0.40$4.42$0.06
$-18.65$-20.94$-18.79
$-0.05$-0.06$-0.01
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$-0.05$-0.06$-0.01
$0$0$0
$-0.04$-0.04$-0.04
$-0.04$-0.04$-0.04
$0$0$78.78
$0$0$78.78
$0$0$0
$0$0$-4.18
$-0.04$-0.04$74.55
$-18.18$-18.79$55.75
$3.08$3.86$6.78
$0$0$0